These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15365577)

  • 1. Is gene therapy the answer for prostate cancer?
    Patel P; Ashdown D; James N
    Prostate Cancer Prostatic Dis; 2004 Sep; 7 Suppl 1():S14-9. PubMed ID: 15365577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer gene therapy: outcome of basic research and clinical trials.
    Nasu Y; Djavan B; Marberger M; Kumon H
    Tech Urol; 1999 Dec; 5(4):185-90. PubMed ID: 10591255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for prostate cancer.
    Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene therapy for prostate cancer].
    Gotoh A; Shirakawa T; Wada Y; Hinata N; Matsubara S; Hara I; Fujisawa M; Okada H; Arakawa S; Kamidono S
    Hinyokika Kiyo; 2002 Nov; 48(11):729-32. PubMed ID: 12512150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for prostate cancer.
    Tangney M; Ahmad S; Collins SA; O'Sullivan GC
    Postgrad Med; 2010 May; 122(3):166-80. PubMed ID: 20463426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for prostate cancer - recent progress in clinical trials.
    Kipp RT; McNeel DG
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Feb; 63(2):335-8. PubMed ID: 15714988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer gene therapy and the role of radiation.
    Kaminski JM; Nguyen K; Buyyounouski M; Pollack A
    Cancer Treat Rev; 2002 Feb; 28(1):49-64. PubMed ID: 12027414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gene therapy for prostate cancer.
    Thompson TC
    Oncol Res; 1999; 11(1):1-8. PubMed ID: 10451026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel targets and approaches in advanced prostate cancer.
    Hadaschik BA; Sowery RD; Gleave ME
    Curr Opin Urol; 2007 May; 17(3):182-7. PubMed ID: 17414516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic.
    Miyake H; Hara I; Gleave ME
    Int J Urol; 2005 Sep; 12(9):785-94. PubMed ID: 16201973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy].
    Gotoh A; Shirakawa T; Wada Y; Hinata N; Terao S; Hara I; Arakawa S; Kamidono S; Okada H; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2005 Feb; 51(2):75-9. PubMed ID: 15773357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate cancer gene therapy].
    Nasu Y; Kumon H
    Nihon Rinsho; 2005 Mar; 63(3):485-90. PubMed ID: 15773349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological principles and clinical development of prostate cancer gene therapy.
    Sanda MG
    Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
    Lu Y
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-modified bone marrow cell therapy for prostate cancer.
    Wang H; Thompson TC
    Gene Ther; 2008 May; 15(10):787-96. PubMed ID: 18385769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE.
    Akaza H; Hinotsu S; Usami M; Ogawa O; Kagawa S; Kitamura T; Tsukamoto T; Naito S; Hirao Y; Murai M; Yamanaka H; Namiki M
    J Urol; 2006 Dec; 176(6 Pt 2):S47-9. PubMed ID: 17084166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional nanoparticles for prostate cancer therapy.
    Salvador-Morales C; Gao W; Ghatalia P; Murshed F; Aizu W; Langer R; Farokhzad OC
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):211-21. PubMed ID: 19192959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy and prostate cancer: what a urologist should know.
    Namiki K; Rosser CJ
    Curr Opin Urol; 2007 May; 17(3):188-93. PubMed ID: 17414517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.